Search results for " natriuretic peptide"

showing 10 items of 81 documents

Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study

2009

Objective To examine the influence of age on the predictive value of N-terminal pro-brain natriuretic (NT-proBNP) peptide assay in acute myocardial infarction. Design Prospective observational study. Setting All intensive care units in one French region. Participants 3291 consecutive patients admitted for an acute myocardial infarction, from the RICO survey (a French regional survey for acute myocardial infarction). Main outcome measure Cardiovascular death at 1 year. Results Among the 3291 participants, mean age was 68 (SD 14) years and 2356 (72%) were men. In the study population, the median NT-proBNP concentration was 1053 (interquartile range 300-3472) pg/ml. Median values for age quart…

AdultMalemedicine.medical_specialtymedicine.drug_classMyocardial InfarctionIschaemic Heart DiseaseDrugs: Cardiovascular SystemPredictive Value of TestsInterquartile rangeInternal medicineIntensive careNatriuretic Peptide BrainFluid Electrolyte and Acid-Base DisturbancesmedicineNatriuretic peptideHumansProspective Studiescardiovascular diseasesMyocardial infarctionProspective cohort studyAgedGeneral Environmental ScienceAged 80 and overFramingham Risk Scorebusiness.industryResearchAdult Intensive CareDiabetesGeneral EngineeringGeneral MedicineMiddle AgedPrognosismedicine.diseaseBrain natriuretic peptidePeptide FragmentsSurgeryHospitalizationCardiovascular DiseasesPredictive value of testsHypertensionGeneral Earth and Planetary SciencesFemaleFrancebusinessBiomarkersBMJ
researchProduct

Brain Natriuretic Peptide and Discovery of Atrial Fibrillation After Stroke

2020

Background and Purpose— Diagnosing paroxysmal atrial fibrillation (pAF) can be challenging after acute ischemic stroke. Enhanced and prolonged Holter-ECG monitoring (EPM) improves the detection rate but is not feasible for all patients. We hypothesized that brain natriuretic peptide (BNP) may help to identify patients with stroke at high risk for pAF to select patients for EPM more effectively. Methods— Patients with acute cerebral ischemia ≥60 years presenting in sinus rhythm and without history of AF were included into a prospective, randomized multicenter study to receive either EPM (3× 10-day Holter-ECG) or usual stroke care diagnostic work-up. BNP plasma levels were measured on random…

Advanced and Specialized Nursingmedicine.medical_specialtyRandomizationbusiness.industryIschemiaAtrial fibrillationPlasma levels030204 cardiovascular system & hematologymedicine.diseaseBrain natriuretic peptide3. Good healthlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineCardiologyMedicineSinus rhythmNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessStroke030217 neurology & neurosurgeryStroke
researchProduct

N-Terminal amino acid sequence analysis indicates that isolated atrial amyloid is derived from atrial natriuretic peptide

1988

Isolated atrial amyloid, the most frequent senile cardiac amyloid type, was chemically analysed. Amyloid fibrils obtained from a patient (NIP) were extracted and the predominant low-molecular-weight polypeptide (approximately 3.5 kDa, designated ASc2 NIP) was isolated by size exclusion high performance liquid chromatography in 60% formic acid. N-Terminal amino acid sequence analysis of this polypeptide was identical to that of the atrial natriuretic peptide alpha-hANP for the first 12 residues determined.

AmyloidAmyloidFormic acidMolecular Sequence DataSize-exclusion chromatographyIsolated atrial amyloidHigh-performance liquid chromatographyPathology and Forensic Medicinechemistry.chemical_compoundAtrial natriuretic peptidechemistryBiochemistrymental disordersHumansNIPFemaleAmino Acid SequencePeptide sequenceAtrial Natriuretic FactorAgedVirchows Archiv B Cell Pathology
researchProduct

Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

2015

Background— Clinical trials in heart failure have focused on the improvement in symptoms or decreases in the risk of death and other cardiovascular events. Little is known about the effect of drugs on the risk of clinical deterioration in surviving patients. Methods and Results— We compared the angiotensin-neprilysin inhibitor LCZ696 (400 mg daily) with the angiotensin-converting enzyme inhibitor enalapril (20 mg daily) in 8399 patients with heart failure and reduced ejection fraction in a double-blind trial. The analyses focused on prespecified measures of nonfatal clinical deterioration. In comparison with the enalapril group, fewer LCZ696-treated patients required intensification of med…

Angiotensin receptorVascular damage Radboud Institute for Health Sciences [Radboudumc 16]receptorsTetrazolesheart failureAngiotensin-Converting Enzyme InhibitorsKaplan-Meier EstimateSacubitrilAngiotensin; Heart failure; Neprilysin; Receptors; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Double-Blind Method; Enalapril; Heart Failure; Humans; Kaplan-Meier Estimate; Natriuretic Peptide Brain; Neprilysin; Peptide Fragments; Risk Factors; Stroke Volume; Survivors; Tetrazoles; Treatment Outcome; Troponin; Disease Progression; Medicine (all); Cardiology and Cardiovascular Medicine; Physiology (medical)AngiotensinEnalaprilRisk FactorsEnalapril/therapeutic useNatriuretic Peptide BrainHeart Failure/bloodSurvivorsReceptorNeprilysinAminobutyrates: Systèmes cardiovasculaire & respiratoire [D03] [Sciences de la santé humaine]Troponin/bloodTroponinAngiotensin Receptor Antagonists/therapeutic useDrug CombinationsAngiotensin-Converting Enzyme Inhibitors/therapeutic useTreatment OutcomeTetrazoles/therapeutic useCardiologyDisease ProgressionValsartanNeprilysinHeart Failure/blood/drug therapy/physiopathologyCardiology and Cardiovascular Medicinemedicine.drugReceptormedicine.medical_specialtyHeart failureneprilysinAngiotensin Receptor Antagonistsreceptors angiotensinDouble-Blind MethodPhysiology (medical)Internal medicineRenin–angiotensin systemmedicineHumansheart failure neprilysin receptors angiotensinEnalaprilbusiness.industryBiphenyl CompoundsStroke Volumemedicine.diseasePeptide FragmentsEndocrinologyAminobutyrates/therapeutic useStroke Volume/physiologyHeart failureNatriuretic Peptide Brain/blood: Cardiovascular & respiratory systems [D03] [Human health sciences]businessNeprilysin/antagonists & inhibitorsPeptide Fragments/bloodSacubitril ValsartanBiomarkersBiomarkers/blood
researchProduct

The natriuretic system in human and murine submandibular salivary glands in health and disease: insights from head and neck tumour cases

2019

Introduction: The wide distribution of the atrial natriuretic peptide was paralleled by a similar presence of its receptors, an indication of the wide range of their biological effects beyond the control of the homeostatic process. This study depicts through immunohistochemical and molecular techniques the distribution and modulation of atrial natriuretic peptide and its receptors in human and murine salivary glands. It also highlights some clinical implications of ANP dysregulation. Methods: Human SMG’s tissue samples were biopsied from normal (3), people with benign (2) or with malignant tumors (8). In addition, biopsies were taken from normal mice (10). They were processed by standard me…

Atrial natriuretic factorAtrial natriuretic peptidemarker for oral carcinomaSubmandibular gland tumor
researchProduct

Atrial Natriuretic Peptide (ANP)-Presence in Human Inferior Turbinate after Treatment Botulinum Toxin Type A Treatment

2012

Atrial natriuretic peptidebusiness.industryMedicineGeneral MedicinePharmacologybusinessAfter treatmentBotulinum toxin typeResearch Journal of Biological Sciences
researchProduct

Iron overload does not potentiate doxorubicin induced cardiotoxicity in vivo in mice and in vitro in cardiomyocytes cell cultures

2013

Background: Doxorubicin (DOX), an anticancer anthracycline, is known to induce serious cardiotoxicity, which is believed to be mediated by oxidative stress and complex interactions with iron. However, the relations between iron metabolism and DOX-induced cardiotoxicity remain a matter of controversy. Methods: Firstly, we used an in vivo murine model of iron overloading (IO) where male C57BL/6 mice received during 3 weeks (D0-D20) a daily dextran-iron injection (15 mg/kg/day.) and then (D21) a single dose of 6 mg/kg DOX. We evaluated cardiac function with echocardiography, myocardial gene's expression, nitro-oxidative stress levels and iron status. Secondly, the anti-proliferative activity o…

Cardiac function curvemedicine.medical_specialtyCardiotoxicityAnthracyclinebusiness.industrymedicine.disease_causeEndocrinologyAtrial natriuretic peptideIn vivoInternal medicinepolycyclic compoundsmedicineDoxorubicinViability assayCardiology and Cardiovascular MedicinebusinessOxidative stressmedicine.drugEuropean Heart Journal
researchProduct

Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive r…

2011

Background— Diastolic dysfunction associated with high blood pressure (BP) leads to cardiac remodeling and fibrosis and progression to congestive heart failure. B-type natriuretic peptide (BNP) has BP-lowering, antifibrotic, and antihypertrophic properties, which makes BNP an attractive agent for attenuating the adverse cardiac remodeling associated with hypertension. In the current study, we tested the effects of sustained cardiac proBNP gene delivery on BP, cardiac function, and remodeling in spontaneously hypertensive rats (SHR). Methods and Results— We used the myocardium-tropic adeno-associated virus serotype 9 (AAV9) vector to achieve continuously enhanced cardiac rat proBNP expressi…

Cardiac function curvemedicine.medical_specialtymedicine.drug_classBNP; Natyriuretic peptides; hypertensive heart diseaseDiastolePhysiology (medical)Internal medicinemedicineNatriuretic peptideNatyriuretic peptidescardiovascular diseasesVentricular remodelingEjection fractionbusiness.industryheart failure natriuretic peptide hypertension.medicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareHypertensive heart diseaseBlood pressureEndocrinologyHeart failurecardiovascular systemCardiologyCardiology and Cardiovascular Medicinebusinesshypertensive heart diseasehormones hormone substitutes and hormone antagonistsBNP
researchProduct

Association between multiple biomarkers and classical risk factors with early carotid atherosclerosis

2013

Carotid atherosclerosisOncologymedicine.medical_specialtyAmino-terminal pro-brain natriuretic peptidebiologybusiness.industryExternal carotid arteryC-reactive proteinCopeptinInternal medicinemedicine.arterymedicineCardiologybiology.proteinMid regional pro adrenomedullinCommon carotid arteryUltrasonographyCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

ANP (Atrial Natriuretic Peptide) presence in the heart of a tunicate, Ciona intestinalis.

2010

Atrial natriuretic peptide was found in the heart of vertebrates, we studied the ANP presence in the heart of Ciona intestinalis. This is animal is very important because of the its evolutionary position between invertebrates and vertebrates. ANP presence was only revealed in myoepithelial cells of the myocardium. Results suggest the hypothesis that ANP is present not only in the vertebrates but also in the invertebrates and in Ciona heart ANP might play a similar role like in the heart of vertebrates.

Cell physiologymedicine.medical_specialtyHistologyPathology and Forensic MedicineAtrial natriuretic peptideInternal medicinebiology.animalANP heart tunicates Ciona intestinalismedicineAnimalsCiona intestinalislcsh:QH573-671ANP - Atrial natriuretic peptidebiologylcsh:CytologyMyocardiumMyoepithelial cellVertebrateGeneral Medicinebiology.organism_classificationCiona intestinalisTunicateCionaEndocrinologyembryonic structurescardiovascular systemAtrial Natriuretic Factorhormones hormone substitutes and hormone antagonistscirculatory and respiratory physiologyFolia Histochemica et Cytobiologica
researchProduct